International Study of Inflammation in COVID-19

CompletedOBSERVATIONAL
Enrollment

4,463

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Covid19Outcome, FatalRespiratory FailureAcute Kidney InjuryInflammation
Interventions
DIAGNOSTIC_TEST

SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase

Biomarkers of inflammation

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Rush University

OTHER

collaborator

Copenhagen University Hospital, Hvidovre

OTHER

collaborator

University of Athens

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

University of Thessaly

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

lead

University of Michigan

OTHER

NCT04818866 - International Study of Inflammation in COVID-19 | Biotech Hunter | Biotech Hunter